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Objectives: During the 2002—2003 season, a new variant of influenza B co-circulated with
influenza A viruses. This study examines the characteristics and outcomes of children with
influenza A and B virus infection vs. other acute respiratory illnesses.
Methods: A retrospective chart review was performed on children with laboratory-confirmed
influenza infection, and influenza negative acute respiratory illnesses that prompted a hospital
visit.
Results: Children with influenza were more often previously healthy and presenting with upper
respiratory symptoms, while influenza negative patients typically had underlying medical condi-
tions, and lower respiratory tract disease. Childrenwith influenza Bwere older, weremore likely to
be in school, and presented with myositis more frequently than those with influenza A. A third of
children with influenza A, and 42% with influenza B required hospitalization. The highest hospita-
lization rateswere in infants under one year. Nohealthy children, and only 15%of thosewith chronic
medical problems, had received influenza vaccine. Vaccine efficacy was estimated to be 82.6%.
Conclusions: Most childrenwith influenzawere previously healthy. Overall, a third of childrenwith
influenza required hospitalization. Influenza A and B were clinically indistinguishable, except for
older age and higher incidence of myositis in patients with influenza B. Influenza vaccine coverage
in both healthy and high-risk children was low.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Influenza is a common childhood disease with attack rates as
high as 30—48% in preschool and school-aged children during* Corresponding author. Tel.: +1 713 798 5248; fax: +1 713 798 6802.
E-mail address: florm@bcm.tmc.edu (F.M. Munoz).
1201-9712/$32.00 # 2006 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2005.10.008epidemics.1—3 Influenza accounts for significant morbidity
and mortality each year, especially in patients with chronic
medical conditions and at the extremes of the age spec-
trum.1,4,5 Influenza has also been associated with increased
incidence of acute otitis media, secondary bacterial pneu-
monia, and febrile seizures.6—8 Antibiotic prescriptions for
children are estimated to increase by 10—30% during the
winter months due to influenza and its complications.1
Deaths due to influenza are more common in the elderlyPublished by Elsevier Ltd. All rights reserved.
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been estimated to be between 0.7 to 3.8 per 100 000.4,9
Rates of excess hospitalizations in children associated with
influenza have varied between studies, ranging from 4 to 104
per 10 000. Hospitalization rates are consistently higher in
patients under 24 months of age.1,10,11
In Houston, Texas, a herald outbreak of influenza B
appeared at the end of the 2001—2002 winter season with
evidence of re-emergence of the Victoria lineage,12 which
last circulated in Houston in 1991. The Yamagata lineage of
the B virus circulated in the interim; therefore, children less
than 12 years of age had never been exposed to this virus
variant. Not much is written in the literature about the
differences in the clinical presentations of influenza A and
B, other than the association of influenza B and encephalitis13
and possibly pneumonia14. A recent study suggested that
children with influenza B are older, and appear less ill than
those with influenza A. This study also reported a higher
incidence of myalgias and myositis with influenza B.15
This descriptive study was designed to examine the char-
acteristics, frequency, and severity of influenza A as com-
pared to influenza B and other viral syndromes in children
seeking medical attention in the hospital emergency depart-
ment and clinics. In addition we estimated hospitalization
rates for influenza and immunization rates in healthy and
high-risk patient populations.
Methods
Population and study period
Texas Children’s Hospital (TCH) is the largest pediatric ter-
tiary care hospital serving the city of Houston and surround-
ing counties. The TCH Diagnostic Virology Laboratory
maintains surveillance of the local activity of influenza
viruses by keeping records of all cases of influenza identified
in clinical specimens submitted throughout the season. Data
were collected from children evaluated for possible influenza
A or B infection at TCH between December 1, 2002 and April
30, 2003. The study period included all the influenza-positive
specimens for the 2002—2003 winter season.
All children between the ages of 0 and 18 years, who had
samples sent from any inpatient or outpatient setting for the
diagnosis of influenza during this period, were considered
eligible subjects. Tests were ordered during routine ambu-
latory care, emergency room visits, or inpatient hospital
stays by the physicians caring for these patients, as they
considered necessary.
Patients with laboratory-confirmed influenza by either
positive rapid tests or positive viral cultures were included
as study cases. Patients who had a specimen submitted based
on the clinical suspicion of influenza by the treating physician
(influenza-like illness) and who were influenza negative by
laboratory testing were considered for comparison. From this
group of influenza-negative patients, one age-matched
patient who presented with an influenza-like syndrome
within the same week was selected as a control for each
influenza-positive patient. A week was defined as the period
between Sunday to Saturday to conform to the weekly
numbering from the Centers for Disease Control and Preven-
tion (CDC). There were no patients in the neonatal intensivecare unit with laboratory-confirmed influenza; therefore,
infants in the neonatal unit with negative tests were
excluded from the influenza negative comparison group.
Texas Children’s Diagnostic Virology Laboratory used the
Directigen Flu A/B (Becton—Dickinson Diagnostic Systems,
Sparks, MD, USA) test for rapid identification by membrane
enzyme immunoassay of viral antigens on all test samples
received. A sample of respiratory secretions was obtained by
nasal wash performed by nurses, respiratory therapists, or
physicians. From every specimen for which a rapid influenza
test was requested, a viral tissue culture was also performed
by previously described standard methods.16 The study was
reviewed and approved by the Baylor College of Medicine and
Affiliated Hospitals institutional review board.
Demographic and clinical characteristics
Demographic and clinical datawere collectedby retrospective
chart review using a standardized form.16 The information
collected for each subject included: age, gender, ethnicity
(white, black, Hispanic, or other), source of insurance (none,
medicaid, private), and health status (presence or absence of
at least one chronic underlying condition including: prema-
turity, cardiac or pulmonary disease, neuromuscular disease,
immunodeficiency, malignancy, transplant, immunotherapy,
and significant congenital anomalies).
To compare the severity of illness, a previously used
hierarchy was followed.16 Lower respiratory infection (LRI)
(laryngotracheobronchitis, bronchiolitis, and pneumonia as
diagnosed by the treating physician) was considered the most
severe. Otitis media or sinusitis was the second most severe,
and upper respiratory infection (URI) the least severe. We
assigned each patient’s disease to one of these categories.
There were some patients in each group who presented only
with vomiting, and although this can be part of an influenza
illness, it is not typically the sole presenting symptom.
Therefore, these patients with no symptoms other than
vomiting were placed in a separate group for the severity
of illness tables. The need for oxygen, non-invasive ventila-
tion or mechanical ventilation, death, need of hospitaliza-
tion, length of stay, and occurrence of a secondary bacterial
infection were also recorded. Data on the influenza vaccina-
tion status of the patient or the patient’s mother during
pregnancy, for infants less than six months of age, was
collected when available in the medical chart or electronic
records at Texas Children’s Hospital. Emergency room phy-
sicians and hospital house staff were sent monthly reminders
during the influenza season to document the influenza immu-
nization history of all patients with influenza-like illnesses.
Presenting symptoms, length of illness (at time of presenta-
tion), viral and bacterial culture results, and prescription of
antivirals or antibiotics were recorded as documented in the
medical record and laboratory computer system.
Statistical analysis
Demographic variables and clinical characteristics were com-
pared using multiway contingency tables and computing Chi-
square values. Fisher’s exact test was used for variables with
n  5. Two-sided t-tests were used to compare numerical
data. For all variables, influenza negative patients were
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Figure 1 Influenza cases in Houston for the 2002—2003 season.compared to influenza positive patients, and the influenza A
group was compared to the influenza B group. All analyses
were univariant, as this was a descriptive study. For all tests,
p < 0.05 was considered significant. Incidence of influenza A
and B was estimated based on the midyear age specific popu-
lation of Harris County (Houston) in 2002—2003. Hospitaliza-
tion rateswere calculatedbasedon theproportion of pediatric
hospital beds at Texas Children’s Hospital in relation to the
total number of pediatric beds available in the county.
Results
Influenza peaked in the Houston area during January and
February (CDC weeks 1—8) (Figure 1), similar to the 2002—Table 1 Patient demographics for each group
Influenza neg. no. (%)a Influenza
Total n = 206 n = 205
Gender
Male 117 (57) 103 (5
Female 89 (43) 102 (5
Age
Average (years) 5.5 5.5
<6 months 36 (17) 33 (1
6—23 months 36 (17) 39 (1
2—18 years 134 (65) 133 (6
Ethnic origin
White 79 (38) c 48 (2
Black 42 (20) 56 (2
Hispanic 78 (38) 94 (4
Other 7 (3) 7 (3
Insurance
Medicaid 80 (39) 83 (4
Private 91 (44) 84 (4
None/self 35 (17) 38 (1
Health status
Healthy 64 (31) 106 (5
Underlying conditions 142 (69) c 99 (4
Exposures
Patient in daycare 20/192 (10) 20/1
Patient in school 80/192 (42) 81/1
Siblings at home 146/210 (70) 137/1
Known ill contacts 49/198 (25) 80/1
a Due to rounding, percentages may not sum to 100.
b Statistically significant difference with p < 0.05.
c p < 0.005.2003 national data from the Centers for Disease Control and
Prevention (CDC). Co-circulation of influenza A (54.6% of
cases, more than two thirds A/H1N1) and influenza B
(45.4% of cases, practically all Victoria B lineage) was
observed throughout the epidemic.17 There were 211 labora-
tory-confirmed cases of influenza at Texas Children’s Hospital
during the study period; 205 (97%) of the charts were avail-
able for review. The charts of 206 children with influenza-like
illness, but negative influenza rapid tests and cultures, were
also reviewed.
The majority of influenza cases (56%) were diagnosed by
viral culture. The observed sensitivity of the Directigen Flu
A/BTM rapid test for influenza Awas 46.7% and for influenza B
was 37.8%, or 45.8% overall. This was lower than the
expected sensitivity (72—86%) for this test. Specificity was
97% as predicted.18 Of note, this poorly sensitive test was
subsequently removed from the market.
Influenza positive vs. influenza negative children
The study groups had a similar distribution of demographic
characteristics such as age, gender, ethnicity, and insurance
status (Table 1). Children with laboratory-confirmed influ-
enza were more likely to be previously healthy while influ-
enza negative children were more likely to have chronicA/B no. (%)a Influenza A no. (%)a Influenza B no. (%)a
n = 112 n = 93
0) 61 (54) 42 (45)
0) 51 (46) 51 (55)
4.6 6.7b
6) 25 (22) 8 (9)
9) 23 (21) 16 (17)
5) 64 (57) 69 (74)
3) 18 (16) 30 (32)b
7) 38 (34) 18 (19)
6) 53 (47) 41 (44)
) 3 (3) 4 (4)
0) 49 (44) 34 (37)
1) 42 (38) 42 (45)
9) 21 (19) 17 (18)
2) c 59 (53) 47 (51)
8) 53 (47) 46 (49)
80 (11) 14/98 (14) 6/82 (7)
80 (45) 35/98 (36) 46/82 (56)b
87 (73) 79/104 (76) 58/83 (70)
96 (41) c 46/108 (43) 34/88 (39)
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Table 2 Presence of underlying conditions in each study group
Influenza neg. no. (%) Any influenza no. (%) Influenza A no. (%) Influenza B no. (%)
Total 206 205 112 93
Patients with at least one: 142 (69)a 99 (48) 53 (47) 46 (49)
Prematurity 21 (10) 23 (11) 13 (12) 10 (11)
BPD 12 (6) 9 (4) 6 (5) 3 (3)
RAD 54 (26) 32 (16) 19 (17) 13 (14)
Other pulmonary disease 26 (13)b 12 (6) 2 (2) 10 (11)
Cardiovascular disease 21 (10) 14 (7) 10 (9) 4 (4)
Neuromuscular disease 22 (11) 11 (5) 3 (3) 8 (9)
Immunodeficiency 5 (2) 3 (1) 3 (3) 0 (0)
Malignancy 26 (13)b 9 (4) 3 (3) 6 (6)
Transplant recipient 19 (9) a 8 (4) 3 (3) 5 (5)
Immunosuppressed 31 (15)b 12 (6) 5 (4) 7 (8)
BPD, bronchopulmonary dysplasia; RAD, reactive airways disease.
a Statistically significant difference p < 0.05.
b p < 0.005.medical conditions; 69% compared to only 48% for the influ-
enza positive cases (OR 0.42, 95% CI 0.28—0.64, p = 0.00003).
The distribution of the different medical conditions found in
both groups was similar, with the exception of a greater
frequency of pulmonary diseases other than asthma, and
immunosuppressive conditions (including malignancy and
organ transplantation) in the influenza negative group
(Table 2). The children with negative influenza tests were
diagnosed with an assortment of viral and bacterial infec-
tions, most commonly bacterial tracheitis or pneumonia
(30%), parainfluenza virus (6.8%), and respiratory syncytial
virus (4.4%).
At the time of initial evaluation, children with laboratory-
confirmed influenza were significantly more likely to present
with fever (OR 3.7, 95% CI 2.17—6.37, p < 0.005), rhinorrhea
or congestion (OR 1.9, 95% CI 1.26—2.88, p < 0.005), or coughTable 3 Patient symptoms at the time of presentation for evalu
Influenza neg.





3.4 (0—30) 3.6 (0—
Fever 136 (66) 180 (88)a
Rhinorrhea/congestion 96 (47) 128 (62)a
Cough 118 (57) 142 (69)b
SOB/diff. breathing 51 (25)a 26 (13)
Vomiting/diarrhea 59 (29) 77 (38)
Headache 28 (14) 37 (18)
Sore throat 29 (14) 33 (16)
Myositis 24 (12) 25 (12)
Stomach ache 14 (7) 7 (3)
Seizure 9 (4) 9 (4)
Chest pain 5 (2) 6 (3)
Decreased oral intake 15 (7) 25 (12)
Apnea 8 (4) 4 (2)
Cyanosis 10 (5) 8 (4)
Other 36 (17) 32 (16)
SOB, shortness of breath.
a p < 0.005.
b Statistically significant p < 0.05.(OR 1.6, 95% CI 1.1—2.57, p < 0.05) when compared to
influenza negative patients (Table 3). Children with respira-
tory diseases other than influenza presented more frequently
with shortness of breath and difficulty breathing (OR 0.44;
95% CI 0.25—0.76, p < 0.005). When the occurrence of clin-
ical symptoms in different age groups was analyzed, fever
was significantly more common in children with laboratory-
confirmed influenza at all ages, but particularly in infants <6
months of age (OR 6.8, 95% CI 1.9—25.3, p < 0.005). Older
children with influenza were more likely to present with a
cough (OR 3.3, 95% CI 1.86—5.8, p < 0.005), while decreased
feeding was often reported in infants <6 months of age (OR
6.7, 95% CI 1.23—28.4, p < 0.05) (Table 4). Febrile seizures
occurred in approximately 5% of children in both study
groups, and no cases of encephalitis occurred in either
patient population.ation of influenza or influenza-like illness
A/B
= 205
Influenza A no. (%)
n = 112
Influenza B no. (%)
n = 93
60) 3.8 (0—60) 3.4 (0—21)
95 (85) 85 (91)
67 (60) 61 (66)
70 (63) 72 (77)
11 (10) 15 (16)
39 (35) 38 (41)
17 (15) 20 (22)
14 (13) 19 (20)
8 (7) 17 (18)b
2 (2) 5 (5)
4 (4) 5 (5)
3 (3) 3 (3)
15 (13) 10 (11)
2 (2) 2 (2)
4 (4) 4 (4)
17 (15) 15 (16)
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Table 4 Prevalence of clinical presentations by age, expressed as the percentage of patients in each group with these symptoms
at the time of presentation













Fever 49 51 74 88a 82b 89a
Rhinorrhea/congestion 73 63 54 94 69 61
Cough 73 60 52 82 62 78a
SOB/diff. breathing 32 34 19 15 26 10
Vomiting/diarrhea 22 20 31 33 38 45
Headache 0 0 21 0 0 28
Sore throat 0 0 22 0 3 24
Myalgia/myositis 0 0 18 0 0 20
Stomach ache 0 0 12 0 0 5
Seizures 3 0 5 0 5 5
Chest pain 0 0 4 0 0 5
Decreased oral intake 3 14 7 27b 13 8
Apnea 16 3 1 12 0 0
Cyanosis 14 3 3 15 5 1
Other 8 20 17 12 21 17
SOB, shortness of breath.
a p < 0.005.
b Statistically significant p < 0.05.These symptoms were consistent with the severity of
illness ranking, demonstrating that patients with influenza
more often presented with febrile upper respiratory illness,
while influenza negative patients had more lower respiratory
tract disease (Table 5). Consequently, children with infec-
tions other than influenza more frequently required supple-
mental oxygen (OR 0.38, 95% CI 0.22—0.64, p < 0.005) and
mechanical ventilation (OR 0.34, 95%CI 0.12—0.93,
p < 0.05). Leukocytosis was also more common in the influ-
enza negative group (Table 6). In addition, children in this
group were more likely to be hospitalized than children with
laboratory-confirmed influenza (61% vs. 37%, respectively,
OR 0.37, 95% CI 0.25—0.57, p < 0.001).
Among children with laboratory-confirmed influenza, the
highest rate of hospitalization was seen in infants less than











URI, upper respiratory infection; OM, otitis media; LRI, lower respirat
a Each patient was placed in only one group, corresponding to their hig
placed in the OM group.
b p < 0.005.
c Statistically significant p < 0.05.
d GI symptoms only, no signs of URI, OM or LRI.
e Patients without any of the above symptoms. Some tests were sent a
symptoms such as myalgias.lization was required in 24.5% of healthy children and 53.5%
of children with chronic conditions ( p < 0.001) for influenza.
In children negative for influenza, hospitalization occurred in
36% of healthy patients and 72.5% of children with chronic
conditions ( p < 0.001).
Antibiotic use was common and in similar frequency in
both study groups, while antivirals were seldom used and
weremore likely to be prescribed in children with laboratory-
confirmed influenza (7% vs. 1% of influenza negative patients,
OR 2.7, 95% CI 0.71—9.2, NS). The data we present are
suggestive of overuse of antibiotics as 43% of children with
a documented influenza virus infection received antibiotics
unnecessarily. Furthermore, 59% of patients in the influenza
negative group received antibiotics. Only 12/79 (15.2%) of
these influenza negative children receiving antibiotics were
diagnosed with a bacterial illness by laboratory evaluation.of patients within each group (ex. influenza negative) who had









ory infection; GI, gastrointestinal.
hest severity score; for example if they had a URI and OM, they were
s pre-operative or pre-transplant work-up, others for non-specific
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Table 6 Patient laboratory findings, hospitalizations, complications and therapies for each group
Influenza neg.
no. (%) n = 206
Influenza A/B
no. (%) n = 205
Influenza A
no. (%) n = 112
Influenza B
no. (%) n = 93
Oxygen 59 (29)a 27 (13) 11 (10) 16 (17)
Non-invasive ventilation 2 (1) 1 (0.5) 0 1 (1)
Mechanical ventilation 17 (8)b 6 (3) 2 (2) 4 (4)
Bacterial infection 17 (8) 23 (11) 8 (7) 15 (16)
WBC (109 cells/L) 12.1a 9 9.6 8.3
Leukopenia <2.5  109 cells/L 12 (6) 6 (3) 1 (1) 5 (5)
Leukocytosis >20  109 cells/L 21 (10)a 4 (2) 4 (4) 0
Platelets (average)  109 cells/L 353 289 324a 252
Thrombocytopenia <50  109 cells/L 7 (3) 4 (2) 1 (1) 3 (3)
Thrombocytopenia <100  109 cells/L 11 (5) 12 (6) 3 (3) 9 (10)b
Thrombocytosis >500  109 cells/L 34 (17) 15 (7) 10 (9) 5 (5)
Death 0 1 0 1
Hospitalization 126 (61)a 76 (37) 37 (33) 39 (42)
Length of stay (LOS) (days) 9.1 6.2 4 8.4
Range of LOS (days) 1—85 1—36 1—12 1—36
Antibiotic therapy 122 (59) 88 (43) 46 (41) 42 (45)
Antiviral therapy 3 (1) 15 (7)b 10 (9) 5 (5)
a p < 0.005.
b Statistically significant p < 0.05.Children being admitted were more likely to receive antibio-
tics. Of the children admitted with influenza, 85.7% (60/70)
received antibiotics, and 50% (30/60) of these children were
under two years of age. Of the influenza negative childrenwho
were admitted, 74.6% (47/63) received antibiotics; in this
group, 40.4% (19/47) were under two years of age.
No deaths occurred in the influenza negative group during
the visit or hospitalization in which the influenza tests were
sent.Onedeathoccurredinapatientwith influenzaB(Table6).
This seven-month-old infant had multiple other medical pro-
blems including chronic lung disease, gastroesophageal reflux
disease, and significant hypoxic injury at birth, which resulted
inplacementofaventriculoperitoneal shunt forhydrocephalus
anda gastrostomy tube.He initiallypresentedwithpneumonia
and sepsis requiring mechanical ventilation, support for hypo-
tension,andantibiotics.Hisrespiratoryculturesgrewinfluenza
B and Pseudomonas species.
The subgroups of influenza positive (n = 106) and negative
patients (n = 64) without underlying conditions were also
examined. There were trends toward more fever, rhinorrhea,
and cough at presentation in the influenza positive group, but
these differences were not statistically significant. Otitis
media was more frequently diagnosed in the influenza nega-Table 7 Hospitalization rates for influenza per 10 000 popu-
lation
Age (years) Influenza A/B Influenza A Influenza B
<1 8 5.3 2.8
1—4 1.8 1.2 0.6
5—8 1.6 0.6 1
10—14 1 0.2 0.9a
15—19 0.2 0.2 0.1
Total 0.7 0.4 0.4
a Statistically significant p < 0.05.tive group (7 vs. 3 patients, p = 0.042). There was no differ-
ence in the incidence of lower respiratory tract disease. No
significant differences were seen in laboratory values, the
occurrence of complications, or length of hospital stay (data
not shown). Twenty-six of the 106 (25%) otherwise healthy
patients with influenza were hospitalized, as were 23 of the
64 (36%) influenza negative patients ( p = 0.1). Only six (5.7%)
of the 106 patients with laboratory-confirmed influenza
received antivirals (two influenza negative also received
antivirals). However, 33% of the healthy patients with influ-
enza and 42% of the healthy influenza negative group
received antibiotics.
Influenza A vs. influenza B
Comparing cases of influenza A to influenza B, we noted that
children with influenza B were on average two years older,
and were more likely to be in school (Table 1). At the time of
presentation, symptoms were similar in both groups except
for an increased incidence of myositis or myalgia in older
patients with influenza B (18% vs. 7%, OR 2.9, 95% CI 1.1—7.8,
p = 0.02) (Table 3). We found no difference in the severity of
illness between the influenza subtypes (Table 5).
Hospitalization was necessary in 33% of cases of influenza
A and 42% of cases of influenza B (Table 7). The only labora-
tory differences between these two groups, was an elevated
platelet count in the influenza A patients compared to
thrombocytopenia in those with influenza B (Table 6).
Influenza immunization status
Immunization status was documented in 198 of the 411 (48%)
study patients. Overall, only 23/198 (11.6%) children had
received influenza vaccine. Twenty-three of 149 (15.4%)
children with chronic high-risk conditions had been immu-
nized. No healthy children of any age or mothers of infants
46 L.K. Hite et al.born during the influenza season reported receipt of influ-
enza vaccine. Only 4/23 patients who received the influenza
vaccine developed influenza, giving an estimated vaccine
efficacy of 82.6%. All had underlying chronic diseases.
Discussion
The 2002—2003 influenza season in Houston, TX was char-
acterized by an equal prevalence of influenza A and B viruses.
Influenza B Victoria lineage had not circulated in the area for
12 years. The combination of these two factors made this an
ideal season for comparing the clinical manifestations of
these two viruses in children.
Texas Children’s Hospital is a large referral center caring
for patients with a variety of acute and chronic medical
conditions. The latter tend to seek medical care more fre-
quently than healthy children, use more services, and have
more laboratory tests obtained. This probably accounts for
the high number of children with underlying conditions in our
study groups. Nevertheless, we observed that children with
laboratory-confirmed influenza were significantly more likely
to be previously healthy and seek medical attention exclu-
sively for symptoms associated with influenza. This finding
supports the concerns on the impact of influenza in otherwise
healthy children.6,11 The majority (65%) of children with
laboratory-confirmed influenza were over two years of age
and were more likely to report an exposure to an ill contact,
usually at school. This is consistent with previous descriptions
of high attack and transmission rates in school-aged children,
and this season it concurred with the circulation of a strain of
influenza B new to this age group. The variety of etiologic
agents identified in the influenza negative group represented
the spectrum of causes of influenza-like illnesses seen during
the influenza season.
Children with laboratory-confirmed influenza were signifi-
cantly more likely to present with symptoms that are non-
specific and limited to the upper airway. However, complica-
tions such as apnea, pneumonia, and secondary bacterial
infections still occurred in children with laboratory-confirmed
influenza, especially if under six months of age. Young infants
aremore likely to present with fever alone, or non-respiratory
symptoms, such as decreased oral intake, vomiting, or diar-
rhea. Influenza-positive and influenza-negative children had a
similar incidence of seizures, musculoskeletal, and gastroin-
testinal symptoms. The occurrence of febrile seizures in
approximately 5% of our patients with influenza is consistent
withprevious reports.16 Rareextrapulmonarycomplicationsof
influenza such as encephalitis were not observed, likely due to
our sample size, since encephalitis associatedwith influenza A
was reported during this season.19 Total hospitalization rates
are probably underestimated in our study since diagnosis
depended on respiratory culture without serology. Impor-
tantly, children with influenza who are otherwise healthy,
present with symptoms that are indistinguishable from symp-
toms caused by other respiratory viruses. Influenza virus infec-
tion was more likely to result in emergency room and acute
care visits in previously healthy children.1,16
Of note this season was the poor sensitivity of the rapid
antigen detection test noted early in the epidemic. This was
attributed to the specific test used, rather than to a labora-
tory error, as other laboratories had a similar experience.20The lack of a rapid diagnosis makes it difficult for clinicians to
begin early antiviral therapy. In our study only 15 (7%)
patients with influenza received antivirals. Antiviral use is
influenced by the confirmation of influenza by rapid tests.21
Almost 50% of the patients in both groups were given anti-
biotics, even though only 8—15% of them had a bacterial
infection. This antibiotic prescription rate may be higher
than normal due to the delay in diagnosis,22 however,
increased antibiotic prescribing during the winter months
is not uncommon.1,10
The American Academy of Pediatrics (AAP) and the CDC’s
Advisory Committee on Immunization Practices current
recommendations are that children six months of age or
older receive influenza vaccine if they have chronic medical
conditions. In 2002, the AAP stated that influenza vaccine
should also be administered to healthy children 6—23 months
of age due to the increased morbidity and hospitalization
rates in this age group.2,23 It is also recommended that
household contacts of patients with underlying conditions
or children 0—23 months of age, and pregnant women in their
second and third trimesters receive vaccination prior to the
start of the influenza season. No mothers of infants less than
six months of age, or healthy children in our study received
influenza vaccination. Only 15% of the children with high-risk
conditions were vaccinated. This rate increased moderately
from the <5% immunization rate reported during our 1997—
1998 season,24 but there is still a strong need for education of
healthcare providers, and a better way to track the vaccine
status of high-risk patients. The estimated vaccine efficacy of
82.6% is consistent with an antigenic match between the
circulating and the vaccine strains.25 During the 2002—2003
winter season influenza A (H1N1), A (H3N2), and influenza B
Victoria lineage circulated. According to the CDC, of the
influenza A strains, 85—100% of those typed were similar to
the vaccine strains, and 100% of the influenza B strains tested
were similar to the vaccine strains.19
In summary, most children with laboratory-confirmed
influenza seeking medical attention were previously healthy.
This is probably because of the high fever associated with
influenza infection, particularly in young infants. We found
no consistent clinical markers to distinguish influenza A or B
from each other or other winter viral infections. The recir-
culation of the Victoria lineage of influenza B did not appear
to increase the morbidity or hospitalization rate in children
considered to be immunologically naı¨ve, and the age group
affected with influenza B tended to be older school-aged
children. Education and improvement in influenza vaccina-
tion is still needed and should be prioritized in general
pediatrics, subspecialty pediatrics, and obstetrics.
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